GRAIL
Developer of Galleri and targeted methylation tools for cancer detection.
$80.00
After-hours close−0.01 (−0.01%)
At close$80.01(−3.02%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$2.60 | — | — |
| Aug 2026 | −$2.66 | −$2.56 | +3.8% |
| May 2026 | −$2.76 | −$2.29 | +17.1% |
| Feb 2026 | −$3.33 | −$2.44 | +26.7% |
| Nov 2025 | −$3.36 | −$2.46 | +26.8% |
The latest year is open to everyone — the 12 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Mar 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Apr 2023 | |||
| Sep 2020 | |||
| Sep 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$2.60 | — | — | $44.3M | — | — |
| Aug 5, 2026 | −$2.66 | −$2.56 | +3.8% | $42.4M | $44.7M | +5.4% |
| May 5, 2026 | −$2.76 | −$2.29 | +17.1% | $39.2M | $40.8M | +4.2% |
| Feb 19, 2026 | −$3.33 | −$2.44 | +26.7% | $43.6M | $43.6M | 0.0% |
| Nov 12, 2025 | −$3.36 | −$2.46 | +26.8% | $34.6M | $36.2M | +4.6% |
The latest year is open to everyone — the 12 quarters behind it read with an account. Sign in | ||||||
| Aug 12, 2025 | ||||||
| May 13, 2025 | ||||||
| Feb 20, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 13, 2024 | ||||||
| Mar 31, 2024 | ||||||
| Dec 31, 2023 | ||||||
| Sep 30, 2023 | ||||||
| Jun 29, 2023 | ||||||
| Apr 2, 2023 | ||||||
| Sep 29, 2020 | ||||||
| Sep 29, 2019 | ||||||